SBT

Device To Detect Microbial Colonization Directly From Clinical Specimens.

产品代码
SBT
器械名称
Device To Detect Microbial Colonization Directly From Clinical Specimens.
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 866.3967
FDA 专业组
Microbiology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件
其中 Summary 已存档
0 份,可直接下载
FDA 历史累计 510(k)
1 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

A device to detect microbial colonization directly from clinical specimens is a qualitative in vitro diagnostic device intended for the detection and identification of microbial-associated targets from patients who are suspected of being colonized with a microbial pathogen and may present a risk of transmission to other patients and health care workers. This device is intended to aid in the detection of microbial colonizers for the prevention and control of infection in healthcare settings when used in conjunction with clinical and laboratory findings.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2024-07-15。

510(k) 号批准日期申请人器械名称摘要
DEN2300922024-07-15Diasorin Molecular, LLCSimplexa C. auris Direct, Simplexa C. auris Positive…
FDA 官方分类页: SBT
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。